This guide reviews ways that telehealth modalities can be used to provide treatment for serious mental illness and substance use disorders among adults, distills the research into recommendations for practice, and provides examples of how these recommendations can be implemented.
Dashboard: Filter Bricks
Main page content
![](/sites/default/files/styles/product_thumbnail_dashboard/public/pep21-06-02-001.png?itok=_RjeXgvV)
![Advisory: Screening and Treatment of Substance Use Disorders among Adolescents (based on TIP 31-32)](/sites/default/files/styles/product_thumbnail_dashboard/public/pep20-06-04-008.png?itok=ROiD1fwG)
This Advisory is based on TIP 31, Screening and Assessing Adolescents for Substance Use Disorders (SUDs) and TIP 32, Treatment of Adolescents with SUDs. It includes recommendations for engaging adolescents in SUD risk assessment, screening, and treatment.
![Advisory: Prescribing Pharmacotherapies for Patients With Alcohol Use Disorder (based on TIP 49)](/sites/default/files/styles/product_thumbnail_dashboard/public/PEP20-02-02-015.jpg?itok=WNuItk8O)
This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence.
![Screening and Assessment of Co-Occurring Disorders in the Justice System](/sites/default/files/styles/product_thumbnail_dashboard/public/pep19-screen-codjs.jpg?itok=Ccalfhjf)
This report provides evidence-based practices for screening and assessment of adults in the justice system with mental illness, substance use disorders, or both. It discusses the importance of instrument selection for screening and assessment and provides detailed descriptions of recommended instruments.
![Medication for the Treatment of Alcohol Use Disorder: A Brief Guide](/sites/default/files/styles/product_thumbnail_dashboard/public/sma15-4907.jpg?itok=odLdsOBH)
This manual provides guidance on the use of medication-assisted treatment for alcohol use misuse. It summarizes approved medications, screening and assessment, treatment planning, and patient monitoring.
![](/sites/default/files/styles/product_thumbnail_dashboard/public/sma15-4907pocketguid.jpg?itok=DPlrwirJ)
This pocket guide is designed as a quick reference for information about medication-assisted treatment for alcohol use disorder. It offers a checklist for prescribing medications to patients and provides a list of approved medications for treatment.
![What does the Research Tell us about Services for Children in Therapeutic/Treatment Foster Care with Behavioral Health Issues?](/sites/default/files/styles/product_thumbnail_dashboard/public/sma14-4842.jpg?itok=Jv4va9Xi)
This report discusses a technical expert panel convened to assess research about therapeutic services for youth living in foster care. It reviews the scientific evidence and expert panel input to identify action items and further research needs.
![Substance Abuse Treatment: Addressing the Specific Needs of Women](/sites/default/files/styles/product_thumbnail_dashboard/public/sma13-4788.jpg?itok=Jqwo40_9)
This quick guide helps administrators of substance use disorder treatment facilities implement programs and services that address the needs of women living with substance use disorders. It addresses patterns of use and the drug screening and treatment needs of women.
![TIP 49: Incorporating Alcohol Pharmacotherapies Into Medical Practice](/sites/default/files/styles/product_thumbnail_dashboard/public/sma13-4380.jpg?itok=CVSZgzU3)
This manual provides clinical practice guidelines for using medications in the medication-assisted treatment of alcohol use disorder. It offers guidance on prescribing acamprosate, disulfiram, oral naltrexone, and extended-release injectable naltrexone. The manual also discusses patient management. Access the literature review.
![TIP 48: Managing Depressive Symptoms in Substance Abuse Clients During Early Recovery](/sites/default/files/styles/product_thumbnail_dashboard/public/sma13-4353.jpg?itok=vwN5yD_O)
This guide helps substance use counselors treat clients with symptoms of depression and substance use conditions. Program administrators will learn how to integrate depression treatment into early drug treatment. The guidelines cover screening, assessment, treatment, counseling, cultural competence, and continuing care.
Displaying 1 - 10 out of 18